EBS Emergent Biosolutions Inc

6.03

-0.03 (-0.50%)

Pre Market

Last Updated: 13:12:34

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Emergent Biosolutions Inc	NYSE:EBS	NYSE	Common Stock

	Price Change	% Change	Share Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.03	-0.50%	6.03				3,593	13:12:34

Form 144 - Report of proposed sale of securities

04/06/2024 9:19pm

Edgar (US Regulatory)

="/Images/box-unchecked.jpg" alt="Checkbox not checked">118101/01/2024COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

KATHRYN ZOON
300 PROFESSIONAL DR
GAITHERSBURG � MD � 20879

RESTRICTED STOCK

05/29/2024

1830

8436.30

KATHRYN ZOON
300 PROFESSIONAL DR
GAITHERSBURG � MD � 20879

RESTRICTED STOCK

05/21/2024

1089

6294.42

144: Remarks and Signature

Remarks

TABLE 1 BREAKDOWN: 5/22/2019 2009 5/20/2021 282 5/20/2022 282 5/25/2023 986 5/22/2020 669 5/22/2021 574 5/22/2022 574 5/19/2024 586 5/24/2020 1535 5/24/2021 489 5/19/2023 587 5/25/2024 595 5/19/2022 503 5/20/2023 329

Date of Notice

06/04/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Kathryn Christine Zoon